Showing results (671-680 of 1,111) with videos related to

Sort By:
Pageof 112
Pediatric Neurology|November 7, 2016
mTOR Inhibition Mitigates Molecular and Biochemical Alterations of Vigabatrin-Induced Visual Field Toxicity in MiceKara R Vogel, Garrett R Ainslie, Michelle A Schmidt, et al.
Orphanet Journal of Rare Diseases|June 3, 2014
Brain-blood amino acid correlates following protein restriction in murine maple syrup urine diseaseKara R Vogel, Erland Arning, Brandi L Wasek, et al.
Vascular and Endovascular Surgery|January 11, 2014
Evaluation of readmission rates for carotid endarterectomy versus carotid artery stenting in the US Medicare populationEdgar Luis Galiñanes, Viktor Y Dombroviskiy, Colleen S Hupp, et al.
Frontiers in Medicine|July 5, 2023
Oxygen and mechanical stretch in the developing lung: risk factors for neonatal and pediatric lung diseaseEmily Y Zhang, Colleen M Bartman, Y S Prakash, et al.
Journal of Pediatric Surgery|October 1, 1985
The use of the portal system for the transplantation of a neonate kidney graft in a child with Wilms' tumorZ Shapira, A Yussim, A Savir, et al.
Open Forum Infectious Diseases|November 11, 2025
Risk Factors for Lyme Disease in the General Population-A Survey of Adults and Caregivers in 28 StatesL Hannah Gould, Madiha Shafquat, Stephanie Duench, et al.
Pharmaceutics|October 28, 2023
Focused Ultrasound-Mediated Delivery of Anti-Programmed Cell Death-Ligand 1 Antibody to the Brain of a Porcine ModelSiaka Fadera, Chinwendu Chukwu, Andrew H Stark, et al.
Journal of Medicinal Chemistry|March 1, 1996
Novel carbamates as potent histamine H3 receptor antagonists with high in vitro and oral in vivo activityH Stark, K Purand, X Ligneau, et al.
The Journal of Pharmacology and Experimental Therapeutics|October 1, 1994
[125I]iodoproxyfan, a new antagonist to label and visualize cerebral histamine H3 receptorsX Ligneau, M Garbarg, M L Vizuete, et al.
Pageof 112